ClinicalTrials.gg
Status unknownNCT03312946Updated Oct 18, 2017

Effect of Vibro-oscillatory Therapy for Improvement of Body Contour and Appearance of Cellulite.

An interventional study of Modellata in Body Fat Distribution and Cellulitis, sponsored by Indústria Brasileira Equipamentos Médicos - IBRAMED. Status unknown at 1 site in Brazil. Open to female participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-18.

Sponsored by Indústria Brasileira Equipamentos Médicos - IBRAMED · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
Female
01

Study summary

OBJECTIVE: To evaluate the efficacy of vibro-oscillatory therapy through an electromedical equipment in improving body contour and appearance of cellulite.

SUBJECTS AND METHODS: A prospective and comparative longitudinal clinical study will be performed in 30 women with cellulitis. Patients will be submitted to data collection and evaluation and before and after vibration-oscillatory therapy.

HYPOTHESES: Patients are expected to show improvement in body contour and cellulite after vibration-oscillatory therapy.

STATISTICAL ANALYSIS: A descriptive analysis will be done before and after vibration-oscillatory therapy, with frequency tables for categorical and descriptive variables (mean, standard deviation, median, minimum and maximum values) for continuous or numerical variables. In order to compare the main variables between the groups and the collection times, the analysis of variance (ANOVA) for repeated measures will be used. Tukey's test will be used to compare the groups. The significance level adopted for the statistical tests will be 5% or p \<0.05.

Read the detailed description

After approval by the institutional committee of Research Ethics, the subjects will be approached by the researcher responsible on the day of their evaluation, where they completed the registration form, after a brief analysis of the inclusion and exclusion criteria of the present study, the individuals included in the study will be collection of anthropometric data: weight, height, BMI, perimeter of the treated region, assessment of the degree of gynoid lipodystrophy, clinical inspection and photographic study of the treated area, ultrasound examination to assess the thickness of the dermis and hypodermis and the examination with Cutometer ® to assess the viscoelasticity of the skin.

Patients will be divided according to the degree of cellulite they present and will be treated with vibration therapy, such as the Modellata® electromedical equipment (Ibramed- Brazilian Industry of Electronic Equipment), being performed three times a week for two months totaling 16 sessions by a dermato-functional physiotherapist.

Data collection and evaluation will be performed before and after treatment.

02

Conditions studied

  • Body Fat Distribution
  • Cellulitis

Browse trials for

03

In context

Cellulitis

160 studies on the registry are indexed under Cellulitis; 14 are open to participants now.

This study's planned enrollment of 30 is below the median of 157 across 124 interventional studies indexed under Cellulitis.

Browse Cellulitis studies →

Lead sponsor

Indústria Brasileira Equipamentos Médicos - IBRAMED is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female gender, over 18 years of age;
  • With considered eutrophic;
  • Cellulite carriers;
  • Non smokers;
  • That they agree to participate and sign the TCLE.

Exclusion criteria

Exclusion Criteria:

  • Male gender;
  • Menopausal women;
  • Have undergone aesthetic treatment in the gluteal region and thighs in the last 6 months;
  • Patients with skin lesions, such as dermatitis and dermatoses;
  • Patients with capillary fragility;
  • Patients with acute deep vein thrombosis (DVT);
  • On or near cancerous lesions;
  • Patients with cardiac pacemaker or other implanted electronic device
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Treatment oscillating vibro

    treatment such as the Modellata electromedical device (Ibramed), in the abdomen, flanks, thigh posterior, inner thigh and buttocks. Being performed twice a week, with a total duration of 50 minutes to the session, being 10 sessions total to end the treatment.

    Device: Modellata

Interventions

  • DeviceModellata

    treatment such as the Modellata electromedical device (Ibramed), in the abdomen, flanks, thigh posterior, inner thigh and buttocks.

06

What researchers measure

Primary outcomes

  1. Improve body contour

    Perimetry, photos, and ultrasound

    Time frame: 1 hour per session (10 sessions 5 weeks).

Secondary outcomes

  1. Improve appearance of cellulite

    perimetry, photos, ultra son, degree of cellulite

    Time frame: 1 hour per session (10 sessions 5 weeks).

07

Study locations

1 of 1 sites recruiting
  • Ibramed - Indústria Brasileira de Equipamentos Médicos
    Amparo, São Paulo 13901-080, Brazil
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2017 (actual). Primary completion is estimated for Dec 2017, 1 month after the start.

Of 18 interventional studies with no phase under Cellulitis, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 27. This study's planned 1 month is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2017
First posted
Oct 18, 2017
StartActual
Oct 13, 2017
Primary completionEst.
Dec 4, 2017
CompletionEst.
Feb 4, 2018
Last update
Oct 18, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03312946
Lead sponsor
Indústria Brasileira Equipamentos Médicos - IBRAMED
Responsible party
Sponsor
First posted
Oct 18, 2017
Start date
Oct 13, 2017
Primary completion
Dec 4, 2017 (estimated)
Completion
Feb 4, 2018 (estimated)
Last update
Oct 18, 2017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion